BENLYSTA (belimumab) injection
BENLYSTA is a prescription medicine used for the treatment of a type of nephritis (kidney inflammation) that’s caused by lupus. This condition is called lupus nephritis. Benlysta is used for lupus nephritis that’s active. If you have active lupus nephritis, it means you’re having symptoms of the disease. Brand Name: BENLYSTA (belimumab) injection, for subcutaneous use Initial U.S. Approval: 2011
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
BENLYSTA (belimumab) injection
Belimumab is used with other medications to treat certain types of systemic lupus erythematosus (SLE or lupus; an autoimmune disease in which the immune system attacks healthy parts of the body such as joints, skin, blood vessels, and organs) in adults and children 5 years of age and older.
BENLYSTA is a B-lymphocyte stimulator (BLyS)-specific inhibitor indicated
for the treatment of:
• patients aged 5 years and older with active systemic lupus erythematosus (SLE) who are receiving standard therapy;
• patients aged 5 years and older with active lupus nephritis who are receiving standard therapy.
Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). It is approved in the United States and Canada, and the European Union to treat systemic lupus erythematosus and lupus nephritis.
Drug (Brand / Generic): BENLYSTA / belimumab
Current Indications: systemic lupus erythematosus and lupus nephritis
Marketed by:: GlaxoSmithKline
Approval Date: 2011
Dosage forms and strengths of BENLYSTA (belimumab) injection
• Intravenous Infusion:
−For Injection: 120 mg or 400 mg of belimumab lyophilized powder in single-dose vial for reconstitution and dilution prior to intravenous infusion.
• Subcutaneous Injection:
−Injection: 200 mg/mL of belimumab in single-dose prefilled autoinjector or single-dose prefilled syringe.
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ BENLYSTA (belimumab) injection ”. Confirmation of the order for BENLYSTA (belimumab) injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to Treatment – BENLYSTA
We have delivered medicines to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha
BENLYSTA Sourcing & Delivery
Alleviare India specializes in sourcing and supplying BENLYSTA, a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of BENLYSTA in India.
How much does BENLYSTA cost in the India?
Kindly reach out to us for BENLYSTA (belimumab) injection price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import BENLYSTA to India?
To import belimumab BENLYSTA, patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:
Valid prescription from a qualified doctor.
Patients’ diagnostic reports.
Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
Valid prescription from the doctor.
Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is BENLYSTA available in India?
BENLYSTA belimumab is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of BENLYSTA (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Please contact or mail @ – info@alleviareindia.com +91 9289711087 / 9289711088 for BENLYSTA availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is belimumab available in India?
The drug, belimumab, which was approved on March 9, 2011, by FDA, is the first ever targeted biological for the treatment of SLE patients with active, autoantibody-positive disease, who are already on standard therapy.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand BENLYSTA (belimumab) injection. The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to BENLYSTA (belimumab) injection , they can inquire and find further information by sending their inquiries to ALS.
We have delivered medicines to following countries – Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, India, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe.
